INSL4 Antikörper (AA 30-139) (FITC)
Kurzübersicht für INSL4 Antikörper (AA 30-139) (FITC) (ABIN7151340)
Target
Alle INSL4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 30-139
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Early placenta insulin-like peptide protein (30-139AA)
-
Isotyp
- IgG
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- INSL4 (Insulin-Like 4 (Placenta) (INSL4))
-
Andere Bezeichnung
- INSL4
-
Hintergrund
-
Background: May play an important role in trophoblast development and in the regulation of bone formation.
Aliases: early placenta insulin like peptide (EPIL) antibody, Early placenta insulin like peptide A chain antibody, Early placenta insulin like peptide antibody, Early placenta insulin like peptide B chain antibody, Early placenta insulin-like peptide A chain antibody, EPIL antibody, INSL4 antibody, INSL4_HUMAN antibody, insulin like 4 antibody, insulin like 4 (placenta) antibody, Insulin like peptide 4 antibody, Insulin-like peptide 4 antibody, OTTHUMP00000021025 antibody, Placentin antibody
-
UniProt
- Q14641
Target
-